Literature DB >> 11356895

Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process.

E Célèrier1, J P Laulin, J B Corcuff, M Le Moal, G Simonnet.   

Abstract

It is difficult to conceive that tolerance and sensitization processes, two apparently opposite phenomena, can concomitantly modify one given biological process, i.e., the processing of pain. We have shown recently that opiates produce not only analgesia but also long-lasting hyperalgesia in rats. This suggests that tolerance to the analgesic effect of an opiate, especially heroin, could be in part the result of an actual sensitization of pronociceptive systems. Here, we show that both magnitude and duration of heroin-induced delayed hyperalgesia increase with intermittent heroin administrations, leading to an apparent decrease in the analgesic effectiveness of a given heroin dose. Our observation that a small dose of heroin which is ineffective for triggering a delayed hyperalgesia in non-heroin-treated rats induced an enhancement in pain sensitivity for several days after a series of heroin administrations is in agreement with the sensitization hypothesis. The effectiveness of the opioid receptor antagonist naloxone to precipitate hyperalgesia in rats that had recovered their pre-drug nociceptive value after single or repeated heroin administrations indicates that heroin-deprived rats were in a new biological state associated with a high level balance between opioid-dependent analgesic systems and pronociceptive systems. Because the NMDA receptor antagonist dizocilpine maleate (MK-801) prevented both heroin-induced long-lasting enhancement in pain sensitivity and naloxone-precipitated hyperalgesia, these findings further suggest that tolerance, sensitization, and one withdrawal symptom, hyperalgesia, are issued from a neuroadaptive process in which NMDA systems play a critical role.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356895      PMCID: PMC6762722     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  37 in total

1.  Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.

Authors:  E Célèrier; J Laulin; A Larcher; M Le Moal; G Simonnet
Journal:  Brain Res       Date:  1999-11-13       Impact factor: 3.252

Review 2.  The psychology and neurobiology of addiction: an incentive-sensitization view.

Authors:  T E Robinson; K C Berridge
Journal:  Addiction       Date:  2000-08       Impact factor: 6.526

Review 3.  A review of the role of anti-opioid peptides in morphine tolerance and dependence.

Authors:  R B Rothman
Journal:  Synapse       Date:  1992-10       Impact factor: 2.562

4.  Hyperalgesic response in a patient receiving high concentrations of spinal morphine.

Authors:  N M Ali
Journal:  Anesthesiology       Date:  1986-10       Impact factor: 7.892

5.  Peripheral and central hyperexcitability: differential signs and symptoms in persistent pain.

Authors:  T J Coderre; J Katz
Journal:  Behav Brain Sci       Date:  1997-09       Impact factor: 12.579

Review 6.  The site of expression of NMDA receptor-dependent LTP: new fuel for an old fire.

Authors:  D M Kullmann; S A Siegelbaum
Journal:  Neuron       Date:  1995-11       Impact factor: 17.173

Review 7.  Opioid therapy for chronic nonmalignant pain: a review of the critical issues.

Authors:  R K Portenoy
Journal:  J Pain Symptom Manage       Date:  1996-04       Impact factor: 3.612

Review 8.  Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.

Authors:  T E Robinson; J B Becker
Journal:  Brain Res       Date:  1986-06       Impact factor: 3.252

9.  Is disease progression the major factor in morphine 'tolerance' in cancer pain treatment?

Authors:  E Collin; P Poulain; A Gauvain-Piquard; G Petit; E Pichard-Leandri
Journal:  Pain       Date:  1993-12       Impact factor: 6.961

10.  Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C.

Authors:  J Mao; D D Price; D J Mayer
Journal:  J Neurosci       Date:  1994-04       Impact factor: 6.167

View more
  70 in total

1.  Episodic withdrawal promotes psychomotor sensitization to morphine.

Authors:  Patrick E Rothwell; Jonathan C Gewirtz; Mark J Thomas
Journal:  Neuropsychopharmacology       Date:  2010-09-01       Impact factor: 7.853

2.  Protracted manifestations of acute dependence after a single morphine exposure.

Authors:  Patrick E Rothwell; Mark J Thomas; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

3.  Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity.

Authors:  Bo Lian; Louis Vera-Portocarrero; Tamara King; Michael H Ossipov; Frank Porreca
Journal:  Brain Res       Date:  2010-08-19       Impact factor: 3.252

4.  Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia.

Authors:  Paula E Park; Joel E Schlosburg; Leandro F Vendruscolo; Gery Schulteis; Scott Edwards; George F Koob
Journal:  Addict Biol       Date:  2013-12-13       Impact factor: 4.280

5.  Transition to drug addiction: a negative reinforcement model based on an allostatic decrease in reward function.

Authors:  Serge H Ahmed; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2005-02-25       Impact factor: 4.530

6.  Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving.

Authors:  Zhen-Yu Ren; Jie Shi; David H Epstein; Jun Wang; Lin Lu
Journal:  Psychopharmacology (Berl)       Date:  2009-01-27       Impact factor: 4.530

7.  Altered quantitative sensory testing outcome in subjects with opioid therapy.

Authors:  Lucy Chen; Charlene Malarick; Lindsey Seefeld; Shuxing Wang; Mary Houghton; Jianren Mao
Journal:  Pain       Date:  2009-02-23       Impact factor: 6.961

8.  Withdrawal-associated injury site pain prevalence and correlates among opioid-using people who inject drugs in Vancouver, Canada.

Authors:  Launette Marie Rieb; Kora DeBeck; Kanna Hayashi; Evan Wood; Ekaterina Nosova; M-J Milloy
Journal:  Drug Alcohol Depend       Date:  2020-08-18       Impact factor: 4.492

9.  Sustained morphine-induced sensitization and loss of diffuse noxious inhibitory controls in dura-sensitive medullary dorsal horn neurons.

Authors:  Akiko Okada-Ogawa; Frank Porreca; Ian D Meng
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

10.  Reduced cold pain tolerance in chronic pain patients following opioid detoxification.

Authors:  Jarred Younger; Peter Barelka; Ian Carroll; Kim Kaplan; Larry Chu; Ravi Prasad; Ray Gaeta; Sean Mackey
Journal:  Pain Med       Date:  2008-06-18       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.